The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis. [electronic resource]
Producer: 20110722Description: 114-43 p. digitalISSN:- 1879-016X
- Administration, Inhalation
- Adrenal Cortex Hormones -- administration & dosage
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Albuterol -- administration & dosage
- Clinical Protocols
- Clinical Trials as Topic
- Delayed-Action Preparations -- adverse effects
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Drug Utilization -- trends
- Ethanolamines -- administration & dosage
- Formoterol Fumarate
- Humans
- Muscarinic Antagonists -- administration & dosage
- Outcome Assessment, Health Care
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Risk Assessment -- methods
- Salmeterol Xinafoate
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.